Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with C
| Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
|---|---|---|---|---|---|---|---|
| C12-15 ALKYL LACTATE | TOPICAL | SOLUTION | 93925361 | GC844VRD7E | 10%w/w | ||
| C13-14 ISOPARAFFIN/LAURETH-7/POLYACRYLAMIDE | TOPICAL | GEL | NA | 100mg | Y | ||
| CAFFEINE | NASAL | SPRAY, METERED | 58082 | 3G6A5W338E | 10mg/1ml | ||
| CAFFEINE | OPHTHALMIC | SOLUTION | 58082 | 3G6A5W338E | 2%w/w | ||
| CAFFEINE | ORAL | GRANULE | 58082 | 3G6A5W338E | NA | ||
| CALCIUM | INTRAMUSCULAR | INJECTION | 7440702 | SY7Q814VUP | NA | ||
| CALCIUM | ORAL | TABLET | 7440702 | SY7Q814VUP | 85.04mg | ||
| CALCIUM ACETATE | ORAL | SOLUTION | 62544 | Y882YXF34X | 3mg/5ml | ||
| CALCIUM ACETATE | ORAL | SYRUP | 62544 | Y882YXF34X | 6mg | ||
| CALCIUM ACETATE | ORAL | TABLET | 62544 | Y882YXF34X | 200mg | ||
| CALCIUM ACETATE | ORAL | TABLET, FILM COATED | 62544 | Y882YXF34X | 140mg | ||
| CALCIUM ACETATE | TOPICAL | CREAM | 62544 | Y882YXF34X | 13mg | ||
| CALCIUM ACETATE | TOPICAL | LOTION | 62544 | Y882YXF34X | NA | ||
| CALCIUM ALGINATE AND AMMONIUM ALGINATE | ORAL | TABLET | NA | 80mg | |||
| CALCIUM CARBONATE | AURICULAR (OTIC) | SOLUTION | 471341 | H0G9379FGK | 0.38%w/w | ||
| CALCIUM CARBONATE | BUCCAL | GUM, CHEWING | 471341 | H0G9379FGK | 3492mg | ||
| CALCIUM CARBONATE | DENTAL | POWDER, DENTIFRICE | 471341 | H0G9379FGK | 0.5mg/mg | ||
| CALCIUM CARBONATE | INTRAVENOUS | SOLUTION | 471341 | H0G9379FGK | 4.02%w/v | ||
| CALCIUM CARBONATE | ORAL | CAPSULE | 471341 | H0G9379FGK | 349.9mg | ||
| CALCIUM CARBONATE | ORAL | CAPSULE, DELAYED RELEASE | 471341 | H0G9379FGK | 20mg | Y | |
| CALCIUM CARBONATE | ORAL | CAPSULE, EXTENDED RELEASE | 471341 | H0G9379FGK | 4mg | ||
| CALCIUM CARBONATE | ORAL | FILM, SOLUBLE | 471341 | H0G9379FGK | 14mg | ||
| CALCIUM CARBONATE | ORAL | TABLET | 471341 | H0G9379FGK | 793mg | ||
| CALCIUM CARBONATE | ORAL | TABLET, CHEWABLE | 471341 | H0G9379FGK | 1650mg | ||
| CALCIUM CARBONATE | ORAL | TABLET, COATED | 471341 | H0G9379FGK | 64.8mg | ||
| CALCIUM CARBONATE | ORAL | TABLET, DELAYED RELEASE | 471341 | H0G9379FGK | 8.4mg | ||
| CALCIUM CARBONATE | ORAL | TABLET, EXTENDED RELEASE | 471341 | H0G9379FGK | 229.7mg | ||
| CALCIUM CARBONATE | ORAL | TABLET, FILM COATED | 471341 | H0G9379FGK | 300mg | ||
| CALCIUM CARBONATE | RESPIRATORY (INHALATION) | SOLUTION | 471341 | H0G9379FGK | 4.02%w/v | ||
| CALCIUM CHLORIDE | INFILTRATION | INJECTION | 10035048 | M4I0D6VV5M | 0.33mg | ||
| CALCIUM CHLORIDE | INTRA-ARTERIAL | INJECTION, SOLUTION | 10035048 | M4I0D6VV5M | 11mg | ||
| CALCIUM CHLORIDE | INTRAMUSCULAR | INJECTION | 10035048 | M4I0D6VV5M | 4%w/v | ||
| CALCIUM CHLORIDE | INTRAMUSCULAR | INJECTION, SOLUTION | 10035048 | M4I0D6VV5M | 0.01%w/v | ||
| CALCIUM CHLORIDE | INTRAOCULAR | SOLUTION | 10035048 | M4I0D6VV5M | 0.48mg | ||
| CALCIUM CHLORIDE | INTRAPERITONEAL | SOLUTION | 10035048 | M4I0D6VV5M | 0.03%w/v | ||
| CALCIUM CHLORIDE | INTRATHECAL | INJECTION, SOLUTION | 10035048 | M4I0D6VV5M | 1mg | ||
| CALCIUM CHLORIDE | INTRAVENOUS | INJECTABLE, LIPOSOMAL | 10035048 | M4I0D6VV5M | 0.03%w/v | ||
| CALCIUM CHLORIDE | INTRAVENOUS | INJECTION | 10035048 | M4I0D6VV5M | 4%w/v | ||
| CALCIUM CHLORIDE | INTRAVENOUS | INJECTION, SOLUTION | 10035048 | M4I0D6VV5M | 11mg | ||
| CALCIUM CHLORIDE | INTRAVITREAL | INJECTION, SUSPENSION | 10035048 | M4I0D6VV5M | 0.05%w/v | ||
| CALCIUM CHLORIDE | OPHTHALMIC | SOLUTION | 10035048 | M4I0D6VV5M | 1mg | ||
| CALCIUM CHLORIDE | OPHTHALMIC | SOLUTION/ DROPS | 10035048 | M4I0D6VV5M | 0.02%w/v | ||
| CALCIUM CHLORIDE | ORAL | CAPSULE | 10035048 | M4I0D6VV5M | 2mg | ||
| CALCIUM CHLORIDE | ORAL | CONCENTRATE | 10035048 | M4I0D6VV5M | 0.08mg/1ml | ||
| CALCIUM CHLORIDE | RESPIRATORY (INHALATION) | CAPSULE | 10035048 | M4I0D6VV5M | 3mg | ||
| CALCIUM CHLORIDE ANHYDROUS | INTRA-ARTERIAL | INJECTION | 10043524 | OFM21057LP | 10mg | ||
| CALCIUM CHLORIDE ANHYDROUS | INTRAVENOUS | INJECTION | 10043524 | OFM21057LP | 10mg | ||
| CALCIUM CITRATE | ORAL | POWDER | 5785444 | MLM29U2X85 | 429mg | ||
| CALCIUM CITRATE | ORAL | TABLET | 5785444 | MLM29U2X85 | 98.95mg | ||
| CALCIUM CITRATE | ORAL | TABLET, FILM COATED | 5785444 | MLM29U2X85 | 309mg | ||
| CALCIUM HYDROXIDE | INTRAVENOUS | INJECTION | 1305620 | PF5DZW74VN | 3.7mg | ||
| CALCIUM HYDROXIDE | ORAL | CAPSULE, EXTENDED RELEASE | 1305620 | PF5DZW74VN | 14mg | ||
| CALCIUM HYDROXIDE | ORAL | SUSPENSION | 1305620 | PF5DZW74VN | ADJ PH | ||
| CALCIUM HYDROXIDE | ORAL | TABLET | 1305620 | PF5DZW74VN | 35mg | ||
| CALCIUM HYDROXIDE | SUBCUTANEOUS | INJECTION | 1305620 | PF5DZW74VN | ADJ PH | ||
| CALCIUM PHOSPHATE | DENTAL | PASTE, DENTIFRICE | 10103465 | 97Z1WI3NDX | 45.93%w/w | ||
| CALCIUM PHOSPHATE | DENTAL | POWDER, DENTIFRICE | 10103465 | 97Z1WI3NDX | 0.11mg/mg | ||
| CALCIUM PHOSPHATE | ORAL | TABLET | 10103465 | 97Z1WI3NDX | 183.94mg | ||
| CALCIUM PHOSPHATE | ORAL | TABLET, COATED | 10103465 | 97Z1WI3NDX | 93.6mg | ||
| CALCIUM PHOSPHATE | ORAL | TABLET, EXTENDED RELEASE | 10103465 | 97Z1WI3NDX | 352.63mg | ||
| CALCIUM PHOSPHATE | ORAL | TABLET, FILM COATED | 10103465 | 97Z1WI3NDX | 362mg | ||
| CALCIUM PHOSPHATE, DIBASIC MONOHYDRATE | ORAL | TABLET | NA | 109.3mg | |||
| CALCIUM PHOSPHATE, MONOBASIC, ANHYDROUS | ORAL | TABLET | 7758238 | 701EKV9RMN | 17mg | ||
| CALCIUM POLYCARBOPHIL | ORAL | LOZENGE | 126040582 | 8F049NKY49 | 480mg | ||
| CALCIUM PYROPHOSPHATE | DENTAL | PASTE, DENTIFRICE | 7790763 | X69NU20D19 | 39%w/w | ||
| CALCIUM PYROPHOSPHATE | ORAL | TABLET | 7790763 | X69NU20D19 | 298.04mg | ||
| CALCIUM SACCHARATE | INTRAVENOUS | INJECTION | 5793895 | 6AP9J91K4V | 0.45%w/v | ||
| CALCIUM SACCHARATE | INTRAVENOUS | INJECTION, SOLUTION | 5793895 | 6AP9J91K4V | 540mg | ||
| CALCIUM SACCHARATE | INTRAVENOUS | SOLUTION | 5793895 | 6AP9J91K4V | 90mg | ||
| CALCIUM SILICATE | ORAL | CAPSULE | 1344952 | S4255P4G5M | 40mg | ||
| CALCIUM SILICATE | ORAL | TABLET | 1344952 | S4255P4G5M | 146.13mg | ||
| CALCIUM SILICATE | ORAL | TABLET, COATED | 1344952 | S4255P4G5M | 155mg | ||
| CALCIUM SILICATE | ORAL | TABLET, EXTENDED RELEASE | 1344952 | S4255P4G5M | 15mg | ||
| CALCIUM SILICATE | ORAL | TABLET, FILM COATED | 1344952 | S4255P4G5M | 731mg | ||
| CALCIUM SILICATE | ORAL | TABLET, ORALLY DISINTEGRATING | 1344952 | S4255P4G5M | 600mg | ||
| CALCIUM STEARATE | BUCCAL | TABLET | 1592230 | 776XM7047L | 1.42mg | ||
| CALCIUM STEARATE | ORAL | CAPSULE | 1592230 | 776XM7047L | 21.1mg | ||
| CALCIUM STEARATE | ORAL | CAPSULE, EXTENDED RELEASE | 1592230 | 776XM7047L | 91.9mg | ||
| CALCIUM STEARATE | ORAL | POWDER | 1592230 | 776XM7047L | 600mg | ||
| CALCIUM STEARATE | ORAL | TABLET | 1592230 | 776XM7047L | 280mg | ||
| CALCIUM STEARATE | ORAL | TABLET, CHEWABLE | 1592230 | 776XM7047L | 240mg | ||
| CALCIUM STEARATE | ORAL | TABLET, COATED | 1592230 | 776XM7047L | 12.2mg | ||
| CALCIUM STEARATE | ORAL | TABLET, DELAYED RELEASE | 1592230 | 776XM7047L | 29mg | ||
| CALCIUM STEARATE | ORAL | TABLET, EXTENDED RELEASE | 1592230 | 776XM7047L | 36mg | ||
| CALCIUM STEARATE | ORAL | TABLET, FILM COATED | 1592230 | 776XM7047L | 16mg | ||
| CALCIUM STEARATE | ORAL | TABLET, ORALLY DISINTEGRATING | 1592230 | 776XM7047L | 112mg | ||
| CALCIUM STEARATE | SUBLINGUAL | TABLET | 1592230 | 776XM7047L | 2mg | ||
| CALCIUM SULFATE | ORAL | CAPSULE | WAT0DDB505 | 141.5mg | |||
| CALCIUM SULFATE | ORAL | CAPSULE, EXTENDED RELEASE | WAT0DDB505 | 1.66mg | |||
| CALCIUM SULFATE | ORAL | TABLET | WAT0DDB505 | 2734mg | |||
| CALCIUM SULFATE | ORAL | TABLET, COATED | WAT0DDB505 | 170mg | |||
| CALCIUM SULFATE | ORAL | TABLET, DELAYED RELEASE | WAT0DDB505 | 127mg | |||
| CALCIUM SULFATE | ORAL | TABLET, EXTENDED RELEASE | WAT0DDB505 | 235mg | |||
| CALCIUM SULFATE ANHYDROUS | ORAL | CAPSULE | 7778189 | E934B3V59H | 50mg | ||
| CALCIUM SULFATE ANHYDROUS | ORAL | TABLET | 7778189 | E934B3V59H | 1396mg | ||
| CALCIUM SULFATE ANHYDROUS | ORAL | TABLET, COATED | 7778189 | E934B3V59H | NA | ||
| CALCIUM SULFATE ANHYDROUS | ORAL | TABLET, EXTENDED RELEASE | 7778189 | E934B3V59H | 250mg | ||
| CALCIUM SULFATE DIHYDRATE | ORAL | CAPSULE | 10101414 | 4846Q921YM | 1353mg | ||
| CALCIUM SULFATE DIHYDRATE | ORAL | CAPSULE, EXTENDED RELEASE | 10101414 | 4846Q921YM | 26.68mg | ||
| CALCIUM SULFATE DIHYDRATE | ORAL | TABLET | 10101414 | 4846Q921YM | 1652mg | ||
| CALCIUM SULFATE DIHYDRATE | ORAL | TABLET, COATED | 10101414 | 4846Q921YM | 214.24mg | ||
| CALCIUM SULFATE DIHYDRATE | ORAL | TABLET, DELAYED RELEASE | 10101414 | 4846Q921YM | 87.2mg | ||
| CALCIUM SULFATE DIHYDRATE | ORAL | TABLET, EXTENDED RELEASE | 10101414 | 4846Q921YM | 260mg | ||
| CALCIUM SULFATE DIHYDRATE | ORAL | TABLET, FILM COATED | 10101414 | 4846Q921YM | 1722mg | ||
| CALDIAMIDE SODIUM | INTRAVENOUS | INJECTION, SOLUTION | 122760912 | 1M6415C70M | 0.02%w/v | ||
| CAMPHOR (SYNTHETIC) | NASAL | JELLY | 76222 | 5TJD82A1ET | 65mg | ||
| CAMPHOR (SYNTHETIC) | OPHTHALMIC | DROPS | 76222 | 5TJD82A1ET | NA | ||
| CANADA BALSAM | TOPICAL | LOTION | 8007474 | K304VI98I3 | 0.5%w/w | ||
| CANDELILLA WAX | ORAL | TABLET | 8006448 | WL0328HX19 | 1mg | ||
| CANDELILLA WAX | ORAL | TABLET, EXTENDED RELEASE | 8006448 | WL0328HX19 | 1mg | ||
| CANDELILLA WAX | ORAL | TABLET, FILM COATED | 8006448 | WL0328HX19 | 0.8mg | ||
| CANDELILLA WAX | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 8006448 | WL0328HX19 | 0.58mg | ||
| CAPRYLIC/CAPRIC TRIGLYCERIDE/LECITHIN/ALCOHOL | ORAL | CAPSULE | NA | NA | |||
| CAPRYLIC/CAPRIC/SUCCINIC TRIGLYCERIDE | SUBLINGUAL | AEROSOL | 97708731 | J4BY50FL78 | NA | ||
| CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8 | ORAL | CAPSULE | 361459383 | 00BT03FSO2 | 2006mg | ||
| CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8 | ORAL | CAPSULE, LIQUID FILLED | 361459383 | 00BT03FSO2 | 3623mg | ||
| CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8 | ORAL | SOLUTION | 361459383 | 00BT03FSO2 | 61.2mg/1ml | ||
| CAPSICUM OLEORESIN | ORAL | SYRUP | 8023776 | UW86K581WY | 0.05mg/5ml | ||
| CAPTAN | TOPICAL | SHAMPOO, SUSPENSION | 133062 | EOL5G26Q9F | 0.15%w/v | ||
| CARAMEL | ORAL | CAPSULE | 8028895 | T9D99G2B1R | NA | ||
| CARAMEL | ORAL | GRANULE, FOR SUSPENSION | 8028895 | T9D99G2B1R | 2.5mg/5ml | ||
| CARAMEL | ORAL | LIQUID | 8028895 | T9D99G2B1R | 5.3mg | ||
| CARAMEL | ORAL | SOLUTION | 8028895 | T9D99G2B1R | 11mg | ||
| CARAMEL | ORAL | SUSPENSION | 8028895 | T9D99G2B1R | 111.12mg/5ml | ||
| CARAMEL | ORAL | SYRUP | 8028895 | T9D99G2B1R | 207mg/5ml | ||
| CARAMEL | RECTAL | SOLUTION | 8028895 | T9D99G2B1R | NA | ||
| CARAMEL | TOPICAL | CREAM | 8028895 | T9D99G2B1R | 0.26%w/w | ||
| CARAMEL | TOPICAL | LOTION | 8028895 | T9D99G2B1R | NA | ||
| CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) | OPHTHALMIC | EMULSION | 71DD5V995L | 0.05%w/v | |||
| CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | CREAM | 71DD5V995L | 25mg | |||
| CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | LOTION | 71DD5V995L | 21mg | |||
| CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | OPHTHALMIC | EMULSION | 809Y72KV36 | 0.05%w/w | |||
| CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | CREAM | 809Y72KV36 | 2mg | |||
| CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | GEL | 809Y72KV36 | 150mg | |||
| CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | LOTION | 809Y72KV36 | 29mg | |||
| CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | TRANSDERMAL | FILM, EXTENDED RELEASE | 809Y72KV36 | 38.9mg | |||
| CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | TRANSDERMAL | GEL | 809Y72KV36 | 0.3%w/w | |||
| CARBOMER COPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | GEL, METERED | 146701613 | 1N11AG4X4L | 32mg | ||
| CARBOMER HOMOPOLYMER | ORAL | TABLET, EXTENDED RELEASE | 0A5MM307FC | 195mg | |||
| CARBOMER HOMOPOLYMER | TOPICAL | DISC | 0A5MM307FC | NA | |||
| CARBOMER HOMOPOLYMER | TOPICAL | GEL | 0A5MM307FC | 0.7%w/w | |||
| CARBOMER HOMOPOLYMER | TOPICAL | LOTION | 0A5MM307FC | 0.53%w/w | |||
| CARBOMER HOMOPOLYMER | TOPICAL | SYSTEM | 0A5MM307FC | 10mg | |||
| CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) | ORAL | CAPSULE | F68VH75CJC | 32mg | |||
| CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) | ORAL | TABLET | F68VH75CJC | 80mg | |||
| CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) | ORAL | TABLET, EXTENDED RELEASE | F68VH75CJC | 525mg | |||
| CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | GEL | F68VH75CJC | 8mg | |||
| CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | LOTION | F68VH75CJC | 43mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | BUCCAL | TABLET | HHT01ZNK31 | 19mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | OPHTHALMIC | GEL | HHT01ZNK31 | 0.48%w/w | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | OPHTHALMIC | SUSPENSION | HHT01ZNK31 | 1mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | OPHTHALMIC | SUSPENSION/ DROPS | HHT01ZNK31 | 0.45%w/v | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | ORAL | CAPSULE | HHT01ZNK31 | 50mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | ORAL | GRANULE, FOR SUSPENSION | HHT01ZNK31 | 600mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | ORAL | SUSPENSION | HHT01ZNK31 | 64mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | ORAL | TABLET | HHT01ZNK31 | 8mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | ORAL | TABLET, EXTENDED RELEASE | HHT01ZNK31 | 180mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | CREAM | HHT01ZNK31 | 214mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | GEL | HHT01ZNK31 | 81mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | LOTION | HHT01ZNK31 | 0.3%w/w | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | OINTMENT | HHT01ZNK31 | 11mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | SOLUTION | HHT01ZNK31 | 11mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | SUSPENSION/ DROPS | HHT01ZNK31 | 0.4%w/v | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | TRANSDERMAL | GEL | HHT01ZNK31 | 19mg | Y | ||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | VAGINAL | GEL | HHT01ZNK31 | 200mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED) | TOPICAL | CREAM, AUGMENTED | 57916924 | K6MOM3T5YL | 15mg | ||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED) | TOPICAL | GEL | 57916924 | K6MOM3T5YL | 175mg | ||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED) | TOPICAL | LOTION | 57916924 | K6MOM3T5YL | 7mg | ||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | OPHTHALMIC | SUSPENSION | Z135WT9208 | 0.45%w/w | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | OPHTHALMIC | SUSPENSION/ DROPS | Z135WT9208 | 0.4%w/v | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | ORAL | CAPSULE | Z135WT9208 | 32mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | ORAL | SUSPENSION | Z135WT9208 | 288mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | ORAL | TABLET, EXTENDED RELEASE | Z135WT9208 | 90mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | ORAL | TABLET, ORALLY DISINTEGRATING | Z135WT9208 | 1mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | RECTAL | ENEMA | Z135WT9208 | 0.24%w/v | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | TOPICAL | CREAM | Z135WT9208 | 1%w/w | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | TOPICAL | CREAM, AUGMENTED | Z135WT9208 | 1%w/w | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | TOPICAL | EMULSION | Z135WT9208 | 0.5%w/w | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | TOPICAL | GEL | Z135WT9208 | 0.95%w/w | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | TOPICAL | GEL, METERED | Z135WT9208 | 1%w/w | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | TOPICAL | LOTION | Z135WT9208 | 0.5%w/w | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | TOPICAL | OINTMENT | Z135WT9208 | 0.5%w/w | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | TOPICAL | SOLUTION | Z135WT9208 | 10mg | |||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | TRANSDERMAL | GEL, METERED | Z135WT9208 | 1%w/w | |||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | OPHTHALMIC | GEL | 4Q93RCW27E | 4%w/w | |||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | CREAM | 4Q93RCW27E | 103mg | |||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | CREAM, AUGMENTED | 4Q93RCW27E | 20mg | |||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | EMULSION | 4Q93RCW27E | 6mg | |||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | GEL | 4Q93RCW27E | 85mg | |||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | LOTION | 4Q93RCW27E | 300mg | |||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | TOPICAL | OINTMENT, AUGMENTED | 4Q93RCW27E | 23mg | |||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | TRANSDERMAL | GEL | 4Q93RCW27E | 90mg | |||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | TRANSDERMAL | GEL, METERED | 4Q93RCW27E | 1%w/w | |||
| CARBON DIOXIDE | INTRAVENOUS | INJECTION | 124389 | 142M471B3J | ADJ PH | ||
| CARBOXYMETHYL STARCH | ORAL | CAPSULE | 9057061 | NA | 15mg | ||
| CARBOXYMETHYL STARCH | ORAL | TABLET | 9057061 | NA | 25mg | ||
| CARBOXYMETHYLCELLULOSE | INTRAMUSCULAR | INJECTION | 9000117 | 05JZI7B19X | 5mg | ||
| CARBOXYMETHYLCELLULOSE | ORAL | CAPSULE, EXTENDED RELEASE | 9000117 | 05JZI7B19X | NA | ||
| CARBOXYMETHYLCELLULOSE | ORAL | DROPS | 9000117 | 05JZI7B19X | 10mg/1ml | ||
| CARBOXYMETHYLCELLULOSE | ORAL | POWDER, FOR SUSPENSION | 9000117 | 05JZI7B19X | NA | ||
| CARBOXYMETHYLCELLULOSE | ORAL | SUSPENSION | 9000117 | 05JZI7B19X | 50.07mg/5ml | ||
| CARBOXYMETHYLCELLULOSE | ORAL | TABLET | 9000117 | 05JZI7B19X | 45mg | ||
| CARBOXYMETHYLCELLULOSE | ORAL | TABLET, DELAYED RELEASE | 9000117 | 05JZI7B19X | NA | ||
| CARBOXYMETHYLCELLULOSE | VAGINAL | JELLY | 9000117 | 05JZI7B19X | NA | ||
| CARBOXYMETHYLCELLULOSE CALCIUM | ORAL | CAPSULE | 9050048 | UTY7PDF93L | 347mg | ||
| CARBOXYMETHYLCELLULOSE CALCIUM | ORAL | TABLET | 9050048 | UTY7PDF93L | 505mg | ||
| CARBOXYMETHYLCELLULOSE CALCIUM | ORAL | TABLET, DELAYED RELEASE | 9050048 | UTY7PDF93L | 13.3mg | ||
| CARBOXYMETHYLCELLULOSE CALCIUM | ORAL | TABLET, FILM COATED | 9050048 | UTY7PDF93L | 241.84mg | ||
| CARBOXYMETHYLCELLULOSE CALCIUM | ORAL | TABLET, ORALLY DISINTEGRATING | 9050048 | UTY7PDF93L | 45mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | BUCCAL | FILM | 9004324 | K679OBS311 | 18mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | BUCCAL | FILM, SOLUBLE | 9004324 | K679OBS311 | 47mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | BUCCAL | TABLET | 9004324 | K679OBS311 | 4mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | DENTAL | GEL | 9004324 | K679OBS311 | 0.4%w/w | ||
| CARBOXYMETHYLCELLULOSE SODIUM | DENTAL | PASTE | 9004324 | K679OBS311 | 16.63%w/w | ||
| CARBOXYMETHYLCELLULOSE SODIUM | DENTAL | PASTE, DENTIFRICE | 9004324 | K679OBS311 | 1.2%w/w | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ENTERAL | SUSPENSION | 9004324 | K679OBS311 | 2920mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | INTRA-ARTICULAR | INJECTION | 9004324 | K679OBS311 | 25mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | INTRA-ARTICULAR | INJECTION, POWDER, FOR SUSPENSION | 9004324 | K679OBS311 | 25mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | INTRA-ARTICULAR | INJECTION, SUSPENSION | 9004324 | K679OBS311 | 30mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | INTRALESIONAL | INJECTION, SUSPENSION | 9004324 | K679OBS311 | 15mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | INTRAMUSCULAR | INJECTION | 9004324 | K679OBS311 | 30mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | INTRAMUSCULAR | INJECTION, POWDER, FOR SUSPENSION | 9004324 | K679OBS311 | 25mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | INTRAMUSCULAR | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 9004324 | K679OBS311 | 5mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | INTRAMUSCULAR | INJECTION, SUSPENSION | 9004324 | K679OBS311 | 30mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | INTRAMUSCULAR | POWDER, FOR SUSPENSION | 9004324 | K679OBS311 | 0.7%w/v | ||
| CARBOXYMETHYLCELLULOSE SODIUM | INTRASYNOVIAL | INJECTION | 9004324 | K679OBS311 | 0.1%w/v | ||
| CARBOXYMETHYLCELLULOSE SODIUM | INTRAVITREAL | INJECTION, SUSPENSION | 9004324 | K679OBS311 | 0.5%w/v | ||
| CARBOXYMETHYLCELLULOSE SODIUM | OPHTHALMIC | SOLUTION | 9004324 | K679OBS311 | 1mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | OPHTHALMIC | SOLUTION/ DROPS | 9004324 | K679OBS311 | 2mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | CAPSULE | 9004324 | K679OBS311 | 160mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | CAPSULE, DELAYED RELEASE | 9004324 | K679OBS311 | 4.2mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | CAPSULE, EXTENDED RELEASE | 9004324 | K679OBS311 | 4mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | GRANULE | 9004324 | K679OBS311 | NA | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | GRANULE, FOR SUSPENSION | 9004324 | K679OBS311 | 15.63mg/5ml | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | PASTE | 9004324 | K679OBS311 | 150mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | POWDER, FOR SOLUTION | 9004324 | K679OBS311 | 161mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | POWDER, FOR SUSPENSION | 9004324 | K679OBS311 | 560mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | SOLUTION | 9004324 | K679OBS311 | 3480mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | SUSPENSION | 9004324 | K679OBS311 | 1600mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | SUSPENSION/ DROPS | 9004324 | K679OBS311 | 12.85mg/2.5ml | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | SYRUP | 9004324 | K679OBS311 | 26.5mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | TABLET | 9004324 | K679OBS311 | 280mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | TABLET, CHEWABLE | 9004324 | K679OBS311 | 24.75mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | TABLET, COATED | 9004324 | K679OBS311 | 3.2mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | TABLET, DELAYED RELEASE | 9004324 | K679OBS311 | 280mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | TABLET, EXTENDED RELEASE | K679OBS311 | 933mg | |||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | TABLET, FILM COATED | 9004324 | K679OBS311 | 50mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004324 | K679OBS311 | 100mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | SOFT TISSUE | INJECTION | 9004324 | K679OBS311 | 0.75%w/v | ||
| CARBOXYMETHYLCELLULOSE SODIUM | SOFT TISSUE | INJECTION, SUSPENSION | 9004324 | K679OBS311 | 15mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | SUBCUTANEOUS | IMPLANT | 9004324 | K679OBS311 | 16mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | TOPICAL | LOTION | 9004324 | K679OBS311 | NA | ||
| CARBOXYMETHYLCELLULOSE SODIUM | TOPICAL | SOLUTION | 9004324 | K679OBS311 | 3000mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM | TOPICAL | SYSTEM | K679OBS311 | 1680mg | |||
| CARBOXYMETHYLCELLULOSE SODIUM | VAGINAL | AEROSOL, FOAM | 9004324 | K679OBS311 | 0.2%w/w | ||
| CARBOXYMETHYLCELLULOSE SODIUM | VAGINAL | CREAM | 9004324 | K679OBS311 | 0.75%w/w | ||
| CARBOXYMETHYLCELLULOSE SODIUM 12 | ORAL | CAPSULE | 9004324 | 0F4M8SIS5K | 4mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM 12 | ORAL | SOLUTION | 9004324 | 0F4M8SIS5K | 1080mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM 12 | ORAL | SUSPENSION | 9004324 | 0F4M8SIS5K | 960mg | ||
| CARBOXYMETHYLCELLULOSE SODIUM 12 | ORAL | TABLET, DELAYED RELEASE | 0F4M8SIS5K | 144mg | |||
| CARBOXYMETHYLCELLULOSE SODIUM 12 | ORAL | TABLET, EXTENDED RELEASE | 0F4M8SIS5K | 160mg | |||
| CARBOXYMETHYLCELLULOSE SODIUM 12, UNSPECIFIED | ORAL | POWDER, FOR SOLUTION | 0F4M8SIS5K | 210mg | |||
| CARMINE | ORAL | SUSPENSION | 1390654 | NA | 50.4mg/5ml | ||
| CARMINE | ORAL | SYRUP | 1390654 | NA | 0.15mg | ||
| CARMINE | ORAL | TABLET | 1390654 | NA | 6.8mg | ||
| CARMINE | ORAL | TABLET, EXTENDED RELEASE | 1390654 | NA | NA | ||
| CARMINE | ORAL | TROCHE | 1390654 | NA | NA | ||
| CARNAUBA WAX | BUCCAL | GUM, CHEWING | 8015869 | R12CBM0EIZ | 10mg | ||
| CARNAUBA WAX | ORAL | CAPSULE | 8015869 | R12CBM0EIZ | NA | ||
| CARNAUBA WAX | ORAL | CAPSULE, EXTENDED RELEASE | 8015869 | R12CBM0EIZ | 288mg | ||
| CARNAUBA WAX | ORAL | TABLET | 8015869 | R12CBM0EIZ | 167.8mg | ||
| CARNAUBA WAX | ORAL | TABLET, CHEWABLE | 8015869 | R12CBM0EIZ | 31.13mg | ||
| CARNAUBA WAX | ORAL | TABLET, COATED | 8015869 | R12CBM0EIZ | 207.5mg | ||
| CARNAUBA WAX | ORAL | TABLET, DELAYED RELEASE | 8015869 | R12CBM0EIZ | 230mg | ||
| CARNAUBA WAX | ORAL | TABLET, EXTENDED RELEASE | 8015869 | R12CBM0EIZ | 2150mg | ||
| CARNAUBA WAX | ORAL | TABLET, FILM COATED | 8015869 | R12CBM0EIZ | 1mg | ||
| CARNAUBA WAX | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 8015869 | R12CBM0EIZ | 140mg | ||
| CARNAUBA WAX | ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 8015869 | R12CBM0EIZ | 0.11mg | ||
| CARNAUBA WAX | ORAL | TABLET, SUGAR COATED | 8015869 | R12CBM0EIZ | NA | ||
| CARNAUBA WAX | TOPICAL | OINTMENT | 8015869 | R12CBM0EIZ | NA | ||
| CARRAGEENAN | DENTAL | PASTE | 9000071 | 5C69YCD2YJ | 0.3%w/w | ||
| CARRAGEENAN | NASAL | POWDER | 9000071 | 5C69YCD2YJ | NA | ||
| CARRAGEENAN | ORAL | CAPSULE | 9000071 | 5C69YCD2YJ | 3mg | ||
| CARRAGEENAN | ORAL | CAPSULE, DELAYED RELEASE | 9000071 | 5C69YCD2YJ | 1mg | ||
| CARRAGEENAN | ORAL | GRANULE, FOR SUSPENSION | 9000071 | 5C69YCD2YJ | 161mg | ||
| CARRAGEENAN | ORAL | POWDER | 9000071 | 5C69YCD2YJ | 1mg | ||
| CARRAGEENAN | ORAL | POWDER, FOR SUSPENSION | 9000071 | 5C69YCD2YJ | 15mg | ||
| CARRAGEENAN | ORAL | SUSPENSION | 9000071 | 5C69YCD2YJ | 6mg/5ml | ||
| CARRAGEENAN | ORAL | TABLET | 9000071 | 5C69YCD2YJ | 15mg | ||
| CARRAGEENAN | RESPIRATORY (INHALATION) | POWDER | 9000071 | 5C69YCD2YJ | 1mg | ||
| CARRAGEENAN | TOPICAL | LOTION | 9000071 | 5C69YCD2YJ | 0.5%w/w | ||
| CARRAGEENAN CALCIUM | ORAL | POWDER, FOR SUSPENSION | 9049052 | 5C4SQ0541D | NA | ||
| CARRAGEENAN SODIUM | TOPICAL | LOTION | 9061829 | 7CY8BVL34N | 1%w/w | ||
| CASTILE SOAP | TOPICAL | SOAP | 8029387 | NA | 97.3%w/w | ||
| CASTOR OIL | INTRAMUSCULAR | INJECTION | 8001794 | D5340Y2I9G | 885mg | ||
| CASTOR OIL | INTRAMUSCULAR | INJECTION, SOLUTION | 8001794 | D5340Y2I9G | 525mg | ||
| CASTOR OIL | NASAL | GEL | 8001794 | D5340Y2I9G | 429mg | ||
| CASTOR OIL | NASAL | SPRAY | 8001794 | D5340Y2I9G | NA | ||
| CASTOR OIL | OPHTHALMIC | EMULSION | 8001794 | D5340Y2I9G | 5%w/v | ||
| CASTOR OIL | ORAL | CAPSULE | 8001794 | D5340Y2I9G | 1.04mg | ||
| CASTOR OIL | ORAL | CAPSULE, EXTENDED RELEASE | 8001794 | D5340Y2I9G | 47mg | ||
| CASTOR OIL | ORAL | GRANULE, FOR SUSPENSION | 8001794 | D5340Y2I9G | 128mg | ||
| CASTOR OIL | ORAL | TABLET | 8001794 | D5340Y2I9G | 17mg | ||
| CASTOR OIL | ORAL | TABLET, COATED | 8001794 | D5340Y2I9G | 0.9mg | ||
| CASTOR OIL | ORAL | TABLET, DELAYED RELEASE | 8001794 | D5340Y2I9G | 0.01mg | ||
| CASTOR OIL | ORAL | TABLET, EXTENDED RELEASE | 8001794 | D5340Y2I9G | 23.27mg | ||
| CASTOR OIL | ORAL | TABLET, FILM COATED | 8001794 | D5340Y2I9G | 15.29mg | ||
| CASTOR OIL | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 8001794 | D5340Y2I9G | NA | ||
| CASTOR OIL | SUBLINGUAL | TABLET | 8001794 | D5340Y2I9G | 1.6mg | ||
| CASTOR OIL | TOPICAL | OINTMENT | 8001794 | D5340Y2I9G | 14.9%w/w | ||
| CASTOR OIL | TOPICAL | SOLUTION | 8001794 | D5340Y2I9G | 1.38%w/w | ||
| CELLABURATE | ORAL | CAPSULE, EXTENDED RELEASE | 9004368 | NA | 33mg | ||
| CELLABURATE | ORAL | TABLET, EXTENDED RELEASE | 9004368 | NA | 177mg | ||
| CELLACEFATE | ORAL | CAPSULE, COATED PELLETS | 9004380 | F2O5O2OI9F | 28.2mg | ||
| CELLACEFATE | ORAL | CAPSULE, EXTENDED RELEASE | 9004380 | F2O5O2OI9F | 9.42mg | ||
| CELLACEFATE | ORAL | TABLET | 9004380 | F2O5O2OI9F | 396mg | Y | |
| CELLACEFATE | ORAL | TABLET, COATED | 9004380 | F2O5O2OI9F | 11.15mg | ||
| CELLACEFATE | ORAL | TABLET, DELAYED RELEASE | 9004380 | F2O5O2OI9F | 419mg | ||
| CELLACEFATE | ORAL | TABLET, EXTENDED RELEASE | 9004380 | F2O5O2OI9F | 70mg | ||
| CELLACEFATE | ORAL | TABLET, FILM COATED | 9004380 | F2O5O2OI9F | 15.6mg | ||
| CELLULOSE ACETATE | ORAL | CAPSULE | 9004357 | 3J2P07GVB6 | 186mg | ||
| CELLULOSE ACETATE | ORAL | TABLET | 9004357 | 3J2P07GVB6 | 27.39mg | ||
| CELLULOSE ACETATE | ORAL | TABLET, CHEWABLE | 9004357 | 3J2P07GVB6 | 27mg | Y | |
| CELLULOSE ACETATE | ORAL | TABLET, EXTENDED RELEASE | 9004357 | 3J2P07GVB6 | 187mg | ||
| CELLULOSE ACETATE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9004357 | 3J2P07GVB6 | 44.6mg | ||
| CELLULOSE ACETATE CA-320S | ORAL | TABLET, EXTENDED RELEASE | NA | 143mg | |||
| CELLULOSE ACETATE CA-398-10 | ORAL | TABLET, EXTENDED RELEASE | NA | 113mg | |||
| CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM | NASAL | SPRAY | NA | 8mg | |||
| CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM | NASAL | SPRAY, METERED | NA | 8mg | |||
| CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM | ORAL | CAPSULE, EXTENDED RELEASE | NA | 144mg | |||
| CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM | ORAL | GRANULE, FOR SUSPENSION | NA | 600mg | |||
| CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM | ORAL | POWDER, FOR SUSPENSION | NA | 800mg | |||
| CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM | ORAL | SUSPENSION | NA | 1500mg | |||
| CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM | ORAL | SUSPENSION/ DROPS | NA | 79mg | |||
| CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM | ORAL | TABLET | NA | 336mg | |||
| CELLULOSE, OXIDIZED | ORAL | TABLET | 9032535 | 44AIH82TSC | 200mg | ||
| CELLULOSE, OXIDIZED | ORAL | TABLET, COATED | 9032535 | 44AIH82TSC | 20mg | ||
| CELLULOSIC POLYMERS | ORAL | CAPSULE, DELAYED RELEASE | NA | NA | |||
| CELLULOSIC POLYMERS | ORAL | TABLET, DELAYED RELEASE | NA | NA | |||
| CELLULOSIC POLYMERS | ORAL | TABLET, EXTENDED RELEASE | NA | NA | |||
| CELLULOSIC POLYMERS | ORAL | TABLET, FILM COATED | NA | NA | |||
| CERESIN | TOPICAL | OINTMENT | 8001750 | Q1LS2UJO3A | 1097mg | ||
| CERESIN | VAGINAL | CREAM | 8001750 | Q1LS2UJO3A | 280mg | ||
| CETEARETH-12 | TOPICAL | AEROSOL, FOAM | 68439496 | 7V4MR24V5P | 200mg | ||
| CETEARETH-12 | TOPICAL | CREAM | 68439496 | 7V4MR24V5P | 5%w/w | ||
| CETEARETH-15 | TOPICAL | CREAM | 68439496 | 867H4YOZ8Z | 20mg | ||
| CETEARETH-30 | TOPICAL | CREAM | 68439496 | 1R9DCZ5FOX | 3%w/w | ||
| CETEARETH-30 | TOPICAL | CREAM, AUGMENTED | 68439496 | 1R9DCZ5FOX | 1%w/w | ||
| CETEARETH-30 | TOPICAL | LOTION | 68439496 | 1R9DCZ5FOX | 2.3%w/w | ||
| CETEARYL ALCOHOL/CETEARETH-20 | TOPICAL | CREAM | NA | 8%w/w | |||
| CETEARYL ALCOHOL/CETEARETH-20 | TOPICAL | CREAM, AUGMENTED | NA | 4.72%w/w | |||
| CETETH-10 | TOPICAL | LOTION | 9004959 | LF9X1PN3XJ | 2.5%w/w | ||
| CETETH-2 | TOPICAL | CREAM | 5274613 | 7H8VAM7778 | 2.59%w/w | ||
| CETETH-2 | TOPICAL | LOTION | 5274613 | 7H8VAM7778 | 0.8%w/w | ||
| CETETH-20 | TOPICAL | CREAM | 9004959 | I835H2IHHX | 6%w/w | ||
| CETETH-20 | TOPICAL | LOTION | 9004959 | I835H2IHHX | 2%w/w | ||
| CETETH-20 | TOPICAL | SOLUTION | 9004959 | I835H2IHHX | 2%w/w | ||
| CETETH-20 | VAGINAL | TAMPON | 9004959 | I835H2IHHX | NA | ||
| CETETH-23 | TOPICAL | CREAM | 9004959 | 495CTZ441V | 2%w/w | ||
| CETOSTEARYL ALCOHOL | ORAL | CAPSULE, EXTENDED RELEASE | 67762270 | 2DMT128M1S | 9.43mg | ||
| CETOSTEARYL ALCOHOL | ORAL | TABLET, EXTENDED RELEASE | 67762270 | 2DMT128M1S | 800mg | ||
| CETOSTEARYL ALCOHOL | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 67762270 | 2DMT128M1S | 62mg | ||
| CETOSTEARYL ALCOHOL | TOPICAL | AEROSOL, FOAM | 67762270 | 2DMT128M1S | 21mg | ||
| CETOSTEARYL ALCOHOL | TOPICAL | CREAM | 67762270 | 2DMT128M1S | 1428mg | ||
| CETOSTEARYL ALCOHOL | TOPICAL | CREAM, AUGMENTED | 67762270 | 2DMT128M1S | 8%w/w | ||
| CETOSTEARYL ALCOHOL | TOPICAL | LOTION | 67762270 | 2DMT128M1S | 3627mg | ||
| CETOSTEARYL ALCOHOL | TOPICAL | OINTMENT | 67762270 | 2DMT128M1S | 1.2%w/w | ||
| CETOSTEARYL ALCOHOL | TOPICAL | SPRAY | 67762270 | 2DMT128M1S | 1%w/w | ||
| CETOSTEARYL ALCOHOL | TOPICAL | SUSPENSION | 67762270 | 2DMT128M1S | 2.5%w/w | ||
| CETOSTEARYL ALCOHOL | VAGINAL | CREAM | 67762270 | 2DMT128M1S | 12%w/w | ||
| CETOSTEARYL ALCOHOL | VAGINAL | SUPPOSITORY | 67762270 | 2DMT128M1S | NA | ||
| CETYL ALCOHOL | AURICULAR (OTIC) | SUSPENSION | 36653824 | 936JST6JCN | 1%w/v | ||
| CETYL ALCOHOL | OPHTHALMIC | SUSPENSION | 36653824 | 936JST6JCN | 0.5%w/v | ||
| CETYL ALCOHOL | ORAL | CAPSULE, DELAYED RELEASE | 36653824 | 936JST6JCN | 59mg | ||
| CETYL ALCOHOL | ORAL | TABLET | 36653824 | 936JST6JCN | NA | ||
| CETYL ALCOHOL | ORAL | TABLET, COATED | 36653824 | 936JST6JCN | 0.25mg | ||
| CETYL ALCOHOL | ORAL | TABLET, EXTENDED RELEASE | 36653824 | 936JST6JCN | 132mg | ||
| CETYL ALCOHOL | ORAL | TABLET, FILM COATED | 36653824 | 936JST6JCN | NA | ||
| CETYL ALCOHOL | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 36653824 | 936JST6JCN | 59mg | ||
| CETYL ALCOHOL | ORAL | TABLET, ORALLY DISINTEGRATING | 36653824 | 936JST6JCN | 9mg | ||
| CETYL ALCOHOL | RECTAL | AEROSOL, FOAM | 36653824 | 936JST6JCN | 17mg | ||
| CETYL ALCOHOL | TOPICAL | AEROSOL | 36653824 | 936JST6JCN | 1.16%w/w | ||
| CETYL ALCOHOL | TOPICAL | AEROSOL, FOAM | 36653824 | 936JST6JCN | 82mg | ||
| CETYL ALCOHOL | TOPICAL | CREAM | 36653824 | 936JST6JCN | 1280mg | ||
| CETYL ALCOHOL | TOPICAL | CREAM, AUGMENTED | 36653824 | 936JST6JCN | 4%w/w | ||
| CETYL ALCOHOL | TOPICAL | EMULSION | 36653824 | 936JST6JCN | NA | ||
| CETYL ALCOHOL | TOPICAL | LOTION | 36653824 | 936JST6JCN | 1140mg | ||
| CETYL ALCOHOL | TOPICAL | OINTMENT | 36653824 | 936JST6JCN | 7%w/w | ||
| CETYL ALCOHOL | TOPICAL | SOLUTION | 36653824 | 936JST6JCN | NA | ||
| CETYL ALCOHOL | TOPICAL | SUSPENSION | 36653824 | 936JST6JCN | 2.01%w/w | ||
| CETYL ALCOHOL | VAGINAL | AEROSOL, FOAM | 36653824 | 936JST6JCN | 0.75%w/w | ||
| CETYL ALCOHOL | VAGINAL | CREAM | 36653824 | 936JST6JCN | 200mg | Y | |
| CETYL ALCOHOL | VAGINAL | SUPPOSITORY | 36653824 | 936JST6JCN | 0.03mg | ||
| CETYL ESTERS WAX | ORAL | POWDER, FOR SUSPENSION | D072FFP9GU | NA | |||
| CETYL ESTERS WAX | TOPICAL | CREAM | D072FFP9GU | 10.3%w/w | |||
| CETYL ESTERS WAX | TOPICAL | LOTION | D072FFP9GU | 1%w/w | |||
| CETYL ESTERS WAX | VAGINAL | CREAM | D072FFP9GU | 3%w/w | |||
| CETYL ESTERS WAX | VAGINAL | SUPPOSITORY | D072FFP9GU | NA | |||
| CETYL PALMITATE | TOPICAL | CREAM | 540103 | 5ZA2S6B08X | 0.32%w/w | ||
| CETYL PALMITATE | TOPICAL | OINTMENT | 540103 | 5ZA2S6B08X | NA | ||
| CETYL PALMITATE | TOPICAL | SOLUTION | 540103 | 5ZA2S6B08X | 0.05%w/w | ||
| CETYL PALMITATE | VAGINAL | CREAM | 540103 | 5ZA2S6B08X | 3.3%w/w | ||
| CETYLPYRIDINIUM CHLORIDE | OPHTHALMIC | SOLUTION | 6004246 | D9OM4SK49P | 0.01%w/w | ||
| CETYLPYRIDINIUM CHLORIDE | ORAL | CAPSULE | 6004246 | D9OM4SK49P | 1.5mg | ||
| CETYLPYRIDINIUM CHLORIDE | ORAL | CAPSULE, EXTENDED RELEASE | 6004246 | D9OM4SK49P | 0.02mg | ||
| CETYLPYRIDINIUM CHLORIDE | RESPIRATORY (INHALATION) | AEROSOL, METERED | 6004246 | D9OM4SK49P | NA | ||
| CETYLPYRIDINIUM CHLORIDE | RESPIRATORY (INHALATION) | AEROSOL, SPRAY | 6004246 | D9OM4SK49P | NA | ||
| CHERRY | ORAL | TABLET | BUC5I9595W | 0.45mg | |||
| CHERRY | ORAL | TABLET, CHEWABLE | BUC5I9595W | NA | |||
| CHLOROBUTANOL | INTRAMUSCULAR | INJECTION | 57158 | HM4YQM8WRC | 0.57%w/v | ||
| CHLOROBUTANOL | INTRAMUSCULAR | SUSPENSION | 57158 | HM4YQM8WRC | 3.5mg | ||
| CHLOROBUTANOL | INTRAVENOUS | INJECTION | 57158 | HM4YQM8WRC | 25mg | ||
| CHLOROBUTANOL | NASAL | DROPS | 57158 | HM4YQM8WRC | 500mg | ||
| CHLOROBUTANOL | NASAL | SOLUTION | 57158 | HM4YQM8WRC | 5.25mg/1ml | ||
| CHLOROBUTANOL | NASAL | SPRAY, METERED | 57158 | HM4YQM8WRC | 20mg | ||
| CHLOROBUTANOL | OPHTHALMIC | DROPS | 57158 | HM4YQM8WRC | 0.5%w/w | ||
| CHLOROBUTANOL | OPHTHALMIC | OINTMENT | 57158 | HM4YQM8WRC | 0.65%w/w | ||
| CHLOROBUTANOL | OPHTHALMIC | SOLUTION | 57158 | HM4YQM8WRC | 1.1%w/v | ||
| CHLOROBUTANOL | ORAL | TABLET | 57158 | HM4YQM8WRC | NA | ||
| CHLOROBUTANOL | PARENTERAL | INJECTION | 57158 | HM4YQM8WRC | 0.5%w/v | ||
| CHLOROBUTANOL | RESPIRATORY (INHALATION) | INHALANT | 57158 | HM4YQM8WRC | 3mg | ||
| CHLOROBUTANOL | RESPIRATORY (INHALATION) | LIQUID | 57158 | HM4YQM8WRC | 0.5%w/w | ||
| CHLOROBUTANOL | RESPIRATORY (INHALATION) | SOLUTION | 57158 | HM4YQM8WRC | 0.5%w/w | ||
| CHLOROBUTANOL | SUBCUTANEOUS | INJECTION | 57158 | HM4YQM8WRC | 0.53%w/v | ||
| CHLOROBUTANOL | TOPICAL | LIQUID | 57158 | HM4YQM8WRC | 0.5%w/w | ||
| CHLOROBUTANOL HEMIHYDRATE | INTRAMUSCULAR | INJECTION | 6001645 | 3X4P6271OX | 26mg | ||
| CHLOROBUTANOL HEMIHYDRATE | INTRAVENOUS | INJECTION | 6001645 | 3X4P6271OX | 26mg | ||
| CHLOROBUTANOL HEMIHYDRATE | INTRAVENOUS | INJECTION, SOLUTION | 6001645 | 3X4P6271OX | 0.53%w/v | ||
| CHLOROBUTANOL HEMIHYDRATE | TOPICAL | SOLUTION | 6001645 | 3X4P6271OX | 0.3%w/w | ||
| CHLOROCRESOL | TOPICAL | CREAM | 59507 | 36W53O7109 | 3mg | ||
| CHLOROCRESOL | TOPICAL | CREAM, AUGMENTED | 59507 | 36W53O7109 | 0.1%w/w | ||
| CHLOROXYLENOL | AURICULAR (OTIC) | SOLUTION | 88040 | 0F32U78V2Q | 0.1%w/w | ||
| CHLOROXYLENOL | TOPICAL | CREAM | 88040 | 0F32U78V2Q | 0.15%w/w | ||
| CHOLESTEROL | EPIDURAL | INJECTION, SUSPENSION, LIPOSOMAL | 57885 | 97C5T2UQ7J | 7mg | ||
| CHOLESTEROL | INFILTRATION | INJECTABLE, LIPOSOMAL | 57885 | 97C5T2UQ7J | 0.47%w/v | ||
| CHOLESTEROL | INTRAVENOUS | INJECTABLE, LIPOSOMAL | 57885 | 97C5T2UQ7J | 437mg | ||
| CHOLESTEROL | INTRAVENOUS | INJECTION | 57885 | 97C5T2UQ7J | 93mg | ||
| CHOLESTEROL | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 57885 | 97C5T2UQ7J | 52mg | ||
| CHOLESTEROL | INTRAVENOUS | INJECTION, SUSPENSION, LIPOSOMAL | 57885 | 97C5T2UQ7J | 0.32%w/v | ||
| CHOLESTEROL | TOPICAL | CREAM | 57885 | 97C5T2UQ7J | 1%w/w | ||
| CHOLESTEROL | TOPICAL | LOTION | 57885 | 97C5T2UQ7J | 1.5%w/w | ||
| CHOLESTEROL | TOPICAL | OINTMENT | 57885 | 97C5T2UQ7J | 5%w/w | ||
| CHOLESTEROL | VAGINAL | CREAM | 57885 | 97C5T2UQ7J | 0.3%w/w | ||
| CHOLETH | VAGINAL | CREAM | 27321966 | NA | 1%w/w | ||
| CHOLETH-24 | TOPICAL | EMULSION | 27321966 | 5UE7I54O43 | 5%w/w | ||
| CHONDRUS CRISPUS | TOPICAL | LOTION | OQS23HUA1X | NA | |||
| CHONDRUS EXTRACT | DENTAL | PASTE, DENTIFRICE | 8015950 | NA | 0.8%w/w | ||
| CHROMA-KOTE T2956-Y YELLOW | ORAL | TABLET | NA | 2.75mg | |||
| CHROMA-KOTE T2956-Y YELLOW | ORAL | TABLET, FILM COATED | NA | 5mg | |||
| CINNAMALDEHYDE | ORAL | SUSPENSION | 14371109 | SR60A3XG0F | NA | ||
| CINNAMALDEHYDE | ORAL | TABLET | 14371109 | SR60A3XG0F | 2.1mg | ||
| CINNAMON | ORAL | CAPSULE | 5S29HWU6QB | NA | |||
| CINNAMON | ORAL | ELIXIR | 5S29HWU6QB | 10.5mg/5ml | |||
| CINNAMON OIL | DENTAL | PASTE, DENTIFRICE | 8015916 | E5GY4I6YCZ | NA | ||
| CINNAMON OIL | DENTAL | POWDER, DENTIFRICE | 8015916 | E5GY4I6YCZ | NA | ||
| CINNAMON OIL | ORAL | ELIXIR | 8015916 | E5GY4I6YCZ | 0.58mg/5ml | ||
| CINNAMON OIL | ORAL | PASTILLE | 8015916 | E5GY4I6YCZ | 4mg | ||
| CINNAMON OIL | ORAL | SUSPENSION | 8015916 | E5GY4I6YCZ | 0.2mg/5ml | ||
| CINNAMON OIL | ORAL | SYRUP | 8015916 | E5GY4I6YCZ | 0.05mg/5ml | ||
| CINNAMON OIL | ORAL | TABLET, CHEWABLE | 8015916 | E5GY4I6YCZ | NA | ||
| CITRIC ACID MONOHYDRATE | AURICULAR (OTIC) | SOLUTION | 5949291 | 2968PHW8QP | 0.2%w/v | ||
| CITRIC ACID MONOHYDRATE | AURICULAR (OTIC) | SOLUTION/ DROPS | 5949291 | 2968PHW8QP | 0.04%w/w | ||
| CITRIC ACID MONOHYDRATE | BUCCAL | SOLUTION | 5949291 | 2968PHW8QP | NA | ||
| CITRIC ACID MONOHYDRATE | BUCCAL | TABLET | 5949291 | 2968PHW8QP | 30mg | ||
| CITRIC ACID MONOHYDRATE | EPIDURAL | INJECTION | 5949291 | 2968PHW8QP | 0.02%w/v | ||
| CITRIC ACID MONOHYDRATE | INFILTRATION | INJECTION | 5949291 | 2968PHW8QP | 0.02%w/v | ||
| CITRIC ACID MONOHYDRATE | INTRA-ARTICULAR | INJECTION | 5949291 | 2968PHW8QP | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | INTRA-ARTICULAR | INJECTION, SOLUTION | 5949291 | 2968PHW8QP | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | INTRABURSAL | INJECTION | 5949291 | 2968PHW8QP | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | INTRACARDIAC | INJECTION | 5949291 | 2968PHW8QP | 1.05%w/v | ||
| CITRIC ACID MONOHYDRATE | INTRALESIONAL | INJECTION | 5949291 | 2968PHW8QP | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | INTRAMUSCULAR | INJECTION | 5949291 | 2968PHW8QP | 28mg | ||
| CITRIC ACID MONOHYDRATE | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 5949291 | 2968PHW8QP | NA | ||
| CITRIC ACID MONOHYDRATE | INTRAMUSCULAR | INJECTION, SOLUTION | 5949291 | 2968PHW8QP | 26mg | ||
| CITRIC ACID MONOHYDRATE | INTRAMUSCULAR | SOLUTION | 5949291 | 2968PHW8QP | 0.05%w/v | ||
| CITRIC ACID MONOHYDRATE | INTRAMUSCULAR | SUSPENSION, EXTENDED RELEASE | 5949291 | 2968PHW8QP | 8mg | ||
| CITRIC ACID MONOHYDRATE | INTRAOCULAR | INJECTION, SOLUTION, CONCENTRATE | 5949291 | 2968PHW8QP | 0.03%w/v | ||
| CITRIC ACID MONOHYDRATE | INTRAOCULAR | SOLUTION | 5949291 | 2968PHW8QP | 1mg | ||
| CITRIC ACID MONOHYDRATE | INTRAPLEURAL | INJECTION | 5949291 | 2968PHW8QP | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | INTRASYNOVIAL | INJECTION | 5949291 | 2968PHW8QP | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | INTRATHECAL | INJECTION | 5949291 | 2968PHW8QP | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | INTRAVENOUS | INJECTION | 5949291 | 2968PHW8QP | 2068mg | ||
| CITRIC ACID MONOHYDRATE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 5949291 | 2968PHW8QP | 608mg | ||
| CITRIC ACID MONOHYDRATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 5949291 | 2968PHW8QP | 385mg | ||
| CITRIC ACID MONOHYDRATE | INTRAVENOUS | INJECTION, SOLUTION | 5949291 | 2968PHW8QP | 396mg | ||
| CITRIC ACID MONOHYDRATE | INTRAVENOUS | LIQUID | 5949291 | 2968PHW8QP | 0.2%w/v | ||
| CITRIC ACID MONOHYDRATE | INTRAVENOUS | SOLUTION | 5949291 | 2968PHW8QP | 10mg | ||
| CITRIC ACID MONOHYDRATE | INTRAVENOUS | SOLUTION, CONCENTRATE | 5949291 | 2968PHW8QP | NA | ||
| CITRIC ACID MONOHYDRATE | IONTOPHORESIS | SOLUTION | 5949291 | 2968PHW8QP | 0.02%w/v | ||
| CITRIC ACID MONOHYDRATE | IONTOPHORESIS | SYSTEM | 5949291 | 2968PHW8QP | 0.2mg | ||
| CITRIC ACID MONOHYDRATE | IRRIGATION | INJECTION, SOLUTION, CONCENTRATE | 5949291 | 2968PHW8QP | 0.03%w/v | ||
| CITRIC ACID MONOHYDRATE | NASAL | SOLUTION | 5949291 | 2968PHW8QP | 2.8mg/1ml | ||
| CITRIC ACID MONOHYDRATE | NASAL | SPRAY | 5949291 | 2968PHW8QP | 9mg | ||
| CITRIC ACID MONOHYDRATE | NASAL | SPRAY, METERED | 5949291 | 2968PHW8QP | 1mg | ||
| CITRIC ACID MONOHYDRATE | OPHTHALMIC | SOLUTION | 5949291 | 2968PHW8QP | 0.03%w/v | ||
| CITRIC ACID MONOHYDRATE | OPHTHALMIC | SOLUTION/ DROPS | 5949291 | 2968PHW8QP | 0.05%w/v | ||
| CITRIC ACID MONOHYDRATE | OPHTHALMIC | SUSPENSION | 5949291 | 2968PHW8QP | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | ORAL | CAPSULE | 5949291 | 2968PHW8QP | 238mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | CAPSULE, EXTENDED RELEASE | 5949291 | 2968PHW8QP | 101mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | CONCENTRATE | 5949291 | 2968PHW8QP | 5.3mg/1ml | ||
| CITRIC ACID MONOHYDRATE | ORAL | DROPS | 5949291 | 2968PHW8QP | NA | ||
| CITRIC ACID MONOHYDRATE | ORAL | ELIXIR | 5949291 | 2968PHW8QP | 100mg/5ml | ||
| CITRIC ACID MONOHYDRATE | ORAL | GRANULE, FOR SUSPENSION | 5949291 | 2968PHW8QP | 113mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | LIQUID | 5949291 | 2968PHW8QP | 114mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | LOZENGE | 5949291 | 2968PHW8QP | 9.8mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | POWDER | 5949291 | 2968PHW8QP | 840mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | POWDER, FOR SOLUTION | 5949291 | 2968PHW8QP | 315mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | POWDER, FOR SUSPENSION | 5949291 | 2968PHW8QP | 840mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | SOLUTION | 5949291 | 2968PHW8QP | 446mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | SUSPENSION | 5949291 | 2968PHW8QP | 269mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | SUSPENSION, EXTENDED RELEASE | 5949291 | 2968PHW8QP | 140.8mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | SUSPENSION/ DROPS | 5949291 | 2968PHW8QP | 19mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | SYRUP | 5949291 | 2968PHW8QP | 722mg/5ml | ||
| CITRIC ACID MONOHYDRATE | ORAL | TABLET | 5949291 | 2968PHW8QP | 914mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | TABLET, CHEWABLE | 5949291 | 2968PHW8QP | 7mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | TABLET, COATED | 5949291 | 2968PHW8QP | NA | ||
| CITRIC ACID MONOHYDRATE | ORAL | TABLET, DELAYED RELEASE | 5949291 | 2968PHW8QP | 1mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | TABLET, EFFERVESCENT | 5949291 | 2968PHW8QP | 460mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | TABLET, EXTENDED RELEASE | 5949291 | 2968PHW8QP | 45mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | TABLET, FILM COATED | 5949291 | 2968PHW8QP | 42mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | TABLET, ORALLY DISINTEGRATING | 5949291 | 2968PHW8QP | 83mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 5949291 | 2968PHW8QP | 2mg | ||
| CITRIC ACID MONOHYDRATE | ORAL | TROCHE | 5949291 | 2968PHW8QP | 12mg | ||
| CITRIC ACID MONOHYDRATE | PARENTERAL | INJECTION | 5949291 | 2968PHW8QP | 8mg | ||
| CITRIC ACID MONOHYDRATE | PERIDURAL | INJECTION | 5949291 | 2968PHW8QP | NA | ||
| CITRIC ACID MONOHYDRATE | PERINEURAL | INJECTION | 5949291 | 2968PHW8QP | 0.02%w/v | ||
| CITRIC ACID MONOHYDRATE | RECTAL | AEROSOL, FOAM | 5949291 | 2968PHW8QP | 7mg | ||
| CITRIC ACID MONOHYDRATE | RESPIRATORY (INHALATION) | INHALANT | 5949291 | 2968PHW8QP | NA | ||
| CITRIC ACID MONOHYDRATE | RESPIRATORY (INHALATION) | LIQUID | 5949291 | 2968PHW8QP | 0.13%w/w | ||
| CITRIC ACID MONOHYDRATE | RESPIRATORY (INHALATION) | SOLUTION | 5949291 | 2968PHW8QP | 8mg | ||
| CITRIC ACID MONOHYDRATE | RESPIRATORY (INHALATION) | SUSPENSION | 5949291 | 2968PHW8QP | 0.03%w/v | ||
| CITRIC ACID MONOHYDRATE | SOFT TISSUE | INJECTION | 5949291 | 2968PHW8QP | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | SUBCUTANEOUS | INJECTION | 5949291 | 2968PHW8QP | 28mg | ||
| CITRIC ACID MONOHYDRATE | SUBCUTANEOUS | INJECTION, SOLUTION | 5949291 | 2968PHW8QP | 26mg | ||
| CITRIC ACID MONOHYDRATE | SUBLINGUAL | FILM | 5949291 | 2968PHW8QP | 10mg | ||
| CITRIC ACID MONOHYDRATE | SUBLINGUAL | TABLET | 5949291 | 2968PHW8QP | 24mg | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | AEROSOL | 5949291 | 2968PHW8QP | 0.11%w/w | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | AEROSOL, FOAM | 5949291 | 2968PHW8QP | 0.11%w/w | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | CREAM | 5949291 | 2968PHW8QP | 4mg | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | CREAM, AUGMENTED | 5949291 | 2968PHW8QP | 0.05%w/w | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | EMULSION | 5949291 | 2968PHW8QP | 0.11%w/w | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | GEL | 5949291 | 2968PHW8QP | 1mg | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | LOTION | 5949291 | 2968PHW8QP | 0.85%w/w | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | OINTMENT | 5949291 | 2968PHW8QP | 1mg | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | POWDER, FOR SOLUTION | 5949291 | 2968PHW8QP | NA | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | SHAMPOO | 5949291 | 2968PHW8QP | 17mg | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | SHAMPOO, SUSPENSION | 5949291 | 2968PHW8QP | 0.25%w/v | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | SOAP | 5949291 | 2968PHW8QP | 0.5%w/w | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | SOLUTION | 5949291 | 2968PHW8QP | 17mg | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | SOLUTION/ DROPS | 5949291 | 2968PHW8QP | 0.01%w/v | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | SWAB | 5949291 | 2968PHW8QP | 0.05%w/w | ||
| CITRIC ACID MONOHYDRATE | TOPICAL | SYSTEM | 5949291 | 2968PHW8QP | 0.2mg | ||
| CITRIC ACID MONOHYDRATE | TRANSDERMAL | FILM, EXTENDED RELEASE | 5949291 | 2968PHW8QP | 1.38mg | ||
| CITRIC ACID MONOHYDRATE | VAGINAL | CREAM | 5949291 | 2968PHW8QP | 0.49%w/w | ||
| CITRIC ACID MONOHYDRATE | VAGINAL | DOUCHE | 5949291 | 2968PHW8QP | 0.07%w/w | ||
| CITRUS SINENSIS FLOWER OIL | ORAL | TABLET | AJ56JP5TFP | NA | |||
| CLOVE OIL | DENTAL | PASTE, DENTIFRICE | 8000348 | 578389D6D0 | 2.4%w/w | ||
| CLOVE OIL | ORAL | ELIXIR | 8000348 | 578389D6D0 | 0.42mg/5ml | ||
| CLOVE OIL | ORAL | SUSPENSION | 8000348 | 578389D6D0 | 0.1mg/5ml | ||
| COCO DIETHANOLAMIDE | TOPICAL | CREAM | 61791319 | 92005F972D | 30mg | ||
| COCO DIETHANOLAMIDE | TOPICAL | SHAMPOO | 61791319 | 92005F972D | 600mg | Y | |
| COCO DIETHANOLAMIDE | TOPICAL | SOLUTION | 61791319 | 92005F972D | 2.5%w/v | ||
| COCO DIETHANOLAMIDE | TOPICAL | SPONGE | 61791319 | 92005F972D | 2%w/w | ||
| COCO DIETHANOLAMIDE | TOPICAL | SUSPENSION | 61791319 | 92005F972D | 4%w/w | ||
| COCO MONOETHANOLAMIDE | TOPICAL | SHAMPOO | 68140001 | C80684146D | 4%w/w | ||
| COCOA | ORAL | SUSPENSION | D9108TZ9KG | 246.66mg/5ml | |||
| COCOA BUTTER | RECTAL | SUPPOSITORY | 8002311 | 512OYT1CRR | 2280mg | ||
| COCO-BETAINE | TOPICAL | SHAMPOO | 68424942 | 03DH2IZ3FY | 133mg | ||
| COCONUT ACID | TOPICAL | SHAMPOO | 61788474 | 40U37V505D | 3%w/w | ||
| COCONUT ACID | TOPICAL | SOAP | 61788474 | 40U37V505D | 7%w/w | ||
| COCONUT ACID | TOPICAL | SOLUTION | 61788474 | 40U37V505D | 0.7%w/w | ||
| COCONUT OIL | ORAL | CAPSULE | 8001318 | Q9L0O73W7L | NA | ||
| COCONUT OIL | ORAL | CAPSULE, LIQUID FILLED | 8001318 | Q9L0O73W7L | NA | ||
| COCONUT OIL | ORAL | TABLET | 8001318 | Q9L0O73W7L | NA | ||
| COCONUT OIL | TOPICAL | AEROSOL, FOAM | 8001318 | Q9L0O73W7L | 23.6%w/w | ||
| COCONUT OIL | TOPICAL | OINTMENT | 8001318 | Q9L0O73W7L | 14.75%w/w | ||
| COCONUT OIL | TOPICAL | SOAP | 8001318 | Q9L0O73W7L | 4.6%w/w | ||
| COCONUT OIL | TOPICAL | SOLUTION | 8001318 | Q9L0O73W7L | 15.5%w/w | ||
| COCONUT OIL/PALM KERNEL OIL GLYCERIDES, HYDROGENATED | RECTAL | SUPPOSITORY | NA | 2000mg | |||
| COCONUT OIL/PALM KERNEL OIL GLYCERIDES, HYDROGENATED | VAGINAL | INSERT | NA | 1229mg | |||
| COCONUT OIL/PALM KERNEL OIL GLYCERIDES, HYDROGENATED | VAGINAL | SUPPOSITORY | NA | NA | |||
| COCONUT OIL/PALM KERNEL OIL GLYCERIDES, HYDROGENATED | VAGINAL | TAMPON | NA | NA | |||
| COCOYL CAPRYLOCAPRATE | TOPICAL | GEL | 52623822 | 8D9H4QU99H | 2.5%w/w | ||
| COFFEE BEAN | ORAL | LIQUID | JFH385Y744 | NA | |||
| COLA NUT | ORAL | CONCENTRATE | PQM9SA369U | 247.2mg/1ml | |||
| COLA NUT | ORAL | SOLUTION | PQM9SA369U | 0.3ml/15ml | |||
| COLA NUT | RECTAL | SOLUTION | PQM9SA369U | 2%v/v | |||
| COLD CREAM | TOPICAL | SOAP | 8050768 | NA | 1.5%w/w | ||
| COLLAGEN | TOPICAL | GEL | 9007345 | NA | 0.02%w/w | ||
| COLLAGEN | TOPICAL | LOTION | 9007345 | NA | 8%w/w | ||
| COLLAGEN | TOPICAL | SHAMPOO | 9007345 | NA | 4.9%w/w | ||
| COLORING SUSPENSION | ORAL | LIQUID | NA | NA | |||
| COMPRESSIBLE SUGAR | ORAL | CAPSULE | NA | 270mg | |||
| COMPRESSIBLE SUGAR | ORAL | CAPSULE, EXTENDED RELEASE | NA | 75mg | |||
| COMPRESSIBLE SUGAR | ORAL | POWDER, FOR SOLUTION | NA | 37039mg | |||
| COMPRESSIBLE SUGAR | ORAL | POWDER, FOR SUSPENSION | NA | 497.3mg | |||
| COMPRESSIBLE SUGAR | ORAL | SOLUTION | NA | 42754mg | |||
| COMPRESSIBLE SUGAR | ORAL | SUSPENSION, EXTENDED RELEASE | NA | 1746mg | |||
| COMPRESSIBLE SUGAR | ORAL | TABLET | NA | 4706mg | |||
| COMPRESSIBLE SUGAR | ORAL | TABLET, CHEWABLE | NA | 3960mg | |||
| COMPRESSIBLE SUGAR | ORAL | TABLET, COATED | NA | 120mg | |||
| COMPRESSIBLE SUGAR | ORAL | TABLET, EXTENDED RELEASE | NA | 708mg | Y | ||
| COMPRESSIBLE SUGAR | ORAL | TABLET, FILM COATED | NA | 400mg | |||
| COMPRESSIBLE SUGAR | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | NA | 354mg | |||
| COMPRESSIBLE SUGAR | SUBLINGUAL | TABLET | NA | 136mg | |||
| COPOVIDONE K25-31 | ORAL | CAPSULE | 25086899 | D9C330MD8B | 1346mg | ||
| COPOVIDONE K25-31 | ORAL | CAPSULE, COATED PELLETS | 25086899 | D9C330MD8B | 88mg | ||
| COPOVIDONE K25-31 | ORAL | CAPSULE, DELAYED RELEASE | 25086899 | D9C330MD8B | 199mg | ||
| COPOVIDONE K25-31 | ORAL | CAPSULE, EXTENDED RELEASE | 25086899 | D9C330MD8B | 200mg | ||
| COPOVIDONE K25-31 | ORAL | PELLET | 25086899 | D9C330MD8B | 1653mg | ||
| COPOVIDONE K25-31 | ORAL | POWDER, FOR SUSPENSION | 25086899 | D9C330MD8B | 5917mg | ||
| COPOVIDONE K25-31 | ORAL | SUSPENSION | 25086899 | D9C330MD8B | 172mg | ||
| COPOVIDONE K25-31 | ORAL | TABLET | 25086899 | D9C330MD8B | 6374mg | ||
| COPOVIDONE K25-31 | ORAL | TABLET, CHEWABLE | 25086899 | D9C330MD8B | 5mg | ||
| COPOVIDONE K25-31 | ORAL | TABLET, DELAYED RELEASE | 25086899 | D9C330MD8B | 168mg | ||
| COPOVIDONE K25-31 | ORAL | TABLET, EXTENDED RELEASE | 25086899 | D9C330MD8B | 300mg | ||
| COPOVIDONE K25-31 | ORAL | TABLET, FILM COATED | 25086899 | D9C330MD8B | 5917mg | ||
| COPOVIDONE K25-31 | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 25086899 | D9C330MD8B | 53mg | ||
| COPOVIDONE K25-31 | ORAL | TABLET, ORALLY DISINTEGRATING | 25086899 | D9C330MD8B | 4.38mg | ||
| COPOVIDONE K25-31 | SUBLINGUAL | TABLET | 25086899 | D9C330MD8B | 54mg | ||
| COPOVIDONE K25-31 | TRANSDERMAL | FILM, EXTENDED RELEASE | 25086899 | D9C330MD8B | NA | ||
| CORIANDER OIL | ORAL | DROPS | 8008524 | 7626GC95E5 | 0.15mg/1ml | ||
| CORIANDER OIL | ORAL | ELIXIR | 8008524 | 7626GC95E5 | 0.03mg | ||
| CORIANDER OIL | ORAL | LIQUID | 8008524 | 7626GC95E5 | 2.5mg | ||
| CORN GLYCERIDES | ORAL | CAPSULE | 85536089 | 1DAF35W3S2 | 1896mg | ||
| CORN GLYCERIDES | ORAL | SOLUTION | 85536089 | 1DAF35W3S2 | 318.85mg/1ml | ||
| CORN OIL | INTRAMUSCULAR | INJECTION | 8001307 | 8470G57WFM | NA | ||
| CORN OIL | ORAL | CAPSULE | 8001307 | 8470G57WFM | 918mg | ||
| CORN OIL | ORAL | SUSPENSION | 8001307 | 8470G57WFM | 2.5ml/5ml | ||
| CORN OIL | ORAL | SUSPENSION, EXTENDED RELEASE | 8001307 | 8470G57WFM | 10mg | ||
| CORN OIL | ORAL | TABLET | 8001307 | 8470G57WFM | 20mg | ||
| CORN OIL | ORAL | TABLET, CHEWABLE | 8001307 | 8470G57WFM | NA | ||
| CORN OIL | ORAL | TABLET, COATED | 8001307 | 8470G57WFM | 10mg | ||
| CORN OIL | ORAL | TABLET, DELAYED RELEASE | 8001307 | 8470G57WFM | 0.03mg | ||
| CORN OIL | ORAL | TABLET, EXTENDED RELEASE | 8001307 | 8470G57WFM | 10mg | ||
| CORN OIL | SUBLINGUAL | TABLET | 8001307 | 8470G57WFM | 1.7mg | ||
| CORN OIL | TOPICAL | CREAM | 8001307 | 8470G57WFM | NA | ||
| CORN OIL MONO- AND DI- GLYCERIDES, C18 | ORAL | CAPSULE, COATED | NA | 86mg | |||
| CORN OIL MONO- AND DI- GLYCERIDES, C18 | ORAL | SOLUTION | NA | NA | |||
| CORN STARCH, PARTIALLY HYDROLYZED | ORAL | TABLET | NA | 80mg | |||
| CORN STARCH, PARTIALLY HYDROLYZED | ORAL | TABLET, CHEWABLE | NA | 14mg | |||
| CORN SYRUP | BUCCAL | TROCHE | 8029434 | 9G5L16BK6N | NA | ||
| CORN SYRUP | ORAL | CAPSULE, EXTENDED RELEASE | 8029434 | 9G5L16BK6N | 28.5mg | ||
| CORN SYRUP | ORAL | ELIXIR | 8029434 | 9G5L16BK6N | 400mg/1ml | ||
| CORN SYRUP | ORAL | SOLUTION | 8029434 | 9G5L16BK6N | 750mg/5ml | ||
| CORN SYRUP | ORAL | SUSPENSION | 8029434 | 9G5L16BK6N | 2500mg/5ml | ||
| CORN SYRUP | ORAL | SUSPENSION, EXTENDED RELEASE | 8029434 | 9G5L16BK6N | 1500mg/5ml | ||
| CORN SYRUP | ORAL | SYRUP | 8029434 | 9G5L16BK6N | 600mg | ||
| CORN SYRUP | ORAL | TABLET | 8029434 | 9G5L16BK6N | 14.07mg | ||
| CORN SYRUP | ORAL | TABLET, COATED | 8029434 | 9G5L16BK6N | 17mg | ||
| CORN SYRUP | ORAL | TROCHE | 8029434 | 9G5L16BK6N | NA | ||
| COTTONSEED OIL | INTRAMUSCULAR | INJECTION | 8001294 | H3E878020N | 1084mg | ||
| COTTONSEED OIL | INTRAMUSCULAR | INJECTION, SOLUTION | 8001294 | H3E878020N | 1120mg | ||
| COTTONSEED OIL | NASAL | SPRAY, METERED | 8001294 | H3E878020N | 1.33mg/0.1ml | ||
| COTTONSEED OIL | ORAL | CAPSULE | 8001294 | H3E878020N | NA | ||
| COTTONSEED OIL | ORAL | TABLET | 8001294 | H3E878020N | 0.16mg | ||
| CREATININE | AURICULAR (OTIC) | SOLUTION | 60275 | AYI8EX34EU | 0.5%w/w | ||
| CREATININE | INTRA-ARTICULAR | INJECTION | 60275 | AYI8EX34EU | 0.8%w/v | ||
| CREATININE | INTRALESIONAL | INJECTION | 60275 | AYI8EX34EU | 0.8%w/v | ||
| CREATININE | INTRAMUSCULAR | INJECTION | 60275 | AYI8EX34EU | 0.8%w/v | ||
| CREATININE | INTRASYNOVIAL | INJECTION | 60275 | AYI8EX34EU | 0.8%w/v | ||
| CREATININE | INTRAVENOUS | INJECTION | 60275 | AYI8EX34EU | 0.8%w/v | ||
| CREATININE | OPHTHALMIC | SOLUTION | 60275 | AYI8EX34EU | 0.5%w/w | ||
| CREATININE | OPHTHALMIC | SOLUTION/ DROPS | 60275 | AYI8EX34EU | 0.2%w/v | ||
| CREATININE | SOFT TISSUE | INJECTION | 60275 | AYI8EX34EU | 0.8%w/v | ||
| CROSCARMELLOSE | ORAL | TABLET | 029TFK992N | 80mg | |||
| CROSCARMELLOSE SODIUM | INTRAMUSCULAR | INJECTION | 74811657 | M28OL1HH48 | 1%w/v | ||
| CROSCARMELLOSE SODIUM | ORAL | CAPSULE | 74811657 | M28OL1HH48 | 257mg | ||
| CROSCARMELLOSE SODIUM | ORAL | CAPSULE, COATED PELLETS | 74811657 | M28OL1HH48 | 198mg | ||
| CROSCARMELLOSE SODIUM | ORAL | CAPSULE, DELAYED RELEASE | 74811657 | M28OL1HH48 | 72mg | ||
| CROSCARMELLOSE SODIUM | ORAL | CAPSULE, EXTENDED RELEASE | 74811657 | M28OL1HH48 | 65.6mg | ||
| CROSCARMELLOSE SODIUM | ORAL | GRANULE | 74811657 | M28OL1HH48 | 150mg | ||
| CROSCARMELLOSE SODIUM | ORAL | GRANULE, FOR SUSPENSION | 74811657 | M28OL1HH48 | 282mg | ||
| CROSCARMELLOSE SODIUM | ORAL | PELLET | 74811657 | M28OL1HH48 | 162mg | ||
| CROSCARMELLOSE SODIUM | ORAL | POWDER, FOR SUSPENSION | 74811657 | M28OL1HH48 | 11.25mg | ||
| CROSCARMELLOSE SODIUM | ORAL | SUSPENSION | 74811657 | M28OL1HH48 | 150mg | ||
| CROSCARMELLOSE SODIUM | ORAL | TABLET | 74811657 | M28OL1HH48 | 736mg | ||
| CROSCARMELLOSE SODIUM | ORAL | TABLET, CHEWABLE | 74811657 | M28OL1HH48 | 165mg | ||
| CROSCARMELLOSE SODIUM | ORAL | TABLET, COATED | 74811657 | M28OL1HH48 | 224mg | ||
| CROSCARMELLOSE SODIUM | ORAL | TABLET, DELAYED RELEASE | 74811657 | M28OL1HH48 | 280mg | ||
| CROSCARMELLOSE SODIUM | ORAL | TABLET, DELAYED RELEASE PARTICLES | 74811657 | M28OL1HH48 | 64mg | ||
| CROSCARMELLOSE SODIUM | ORAL | TABLET, EXTENDED RELEASE | 74811657 | M28OL1HH48 | 392mg | ||
| CROSCARMELLOSE SODIUM | ORAL | TABLET, FILM COATED | 74811657 | M28OL1HH48 | 330mg | ||
| CROSCARMELLOSE SODIUM | ORAL | TABLET, FOR SUSPENSION | 74811657 | M28OL1HH48 | 1875mg | ||
| CROSCARMELLOSE SODIUM | ORAL | TABLET, ORALLY DISINTEGRATING | 74811657 | M28OL1HH48 | 144mg | ||
| CROSCARMELLOSE SODIUM | ORAL | TROCHE | 74811657 | M28OL1HH48 | 50mg | ||
| CROSCARMELLOSE SODIUM | SUBLINGUAL | TABLET | 74811657 | M28OL1HH48 | 10mg | ||
| CROSPOVIDONE | INTRAVENOUS | INJECTION | 9003398 | 2S7830E561 | 1.4mg | ||
| CROSPOVIDONE | OPHTHALMIC | SOLUTION | 9003398 | 2S7830E561 | 3%w/w | ||
| CROSPOVIDONE | ORAL | CAPSULE | 9003398 | 2S7830E561 | 250mg | ||
| CROSPOVIDONE | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 9003398 | 2S7830E561 | NA | ||
| CROSPOVIDONE | ORAL | CAPSULE, DELAYED RELEASE | 9003398 | 2S7830E561 | 365mg | Y | |
| CROSPOVIDONE | ORAL | CAPSULE, EXTENDED RELEASE | 9003398 | 2S7830E561 | 25.1mg | ||
| CROSPOVIDONE | ORAL | GRANULE | 9003398 | 2S7830E561 | 238mg | ||
| CROSPOVIDONE | ORAL | GRANULE, FOR SOLUTION | 9003398 | 2S7830E561 | 36.3mg/120ml | ||
| CROSPOVIDONE | ORAL | GRANULE, FOR SUSPENSION | 9003398 | 2S7830E561 | 810mg | ||
| CROSPOVIDONE | ORAL | PELLET | 9003398 | 2S7830E561 | 28mg | ||
| CROSPOVIDONE | ORAL | SUSPENSION | 9003398 | 2S7830E561 | 114mg | ||
| CROSPOVIDONE | ORAL | SUSPENSION, EXTENDED RELEASE | 9003398 | 2S7830E561 | 186.8mg | ||
| CROSPOVIDONE | ORAL | TABLET | 9003398 | 2S7830E561 | 2352mg | ||
| CROSPOVIDONE | ORAL | TABLET, CHEWABLE | 9003398 | 2S7830E561 | 300mg | ||
| CROSPOVIDONE | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 9003398 | 2S7830E561 | 90mg | ||
| CROSPOVIDONE | ORAL | TABLET, COATED | 9003398 | 2S7830E561 | 208mg | ||
| CROSPOVIDONE | ORAL | TABLET, DELAYED RELEASE | 9003398 | 2S7830E561 | 336mg | ||
| CROSPOVIDONE | ORAL | TABLET, EXTENDED RELEASE | 9003398 | 2S7830E561 | 624mg | ||
| CROSPOVIDONE | ORAL | TABLET, FILM COATED | 9003398 | 2S7830E561 | 787mg | ||
| CROSPOVIDONE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 9003398 | 2S7830E561 | 24mg | ||
| CROSPOVIDONE | ORAL | TABLET, FOR SUSPENSION | 9003398 | 2S7830E561 | 1733mg | ||
| CROSPOVIDONE | ORAL | TABLET, ORALLY DISINTEGRATING | 9003398 | 2S7830E561 | 1260mg | ||
| CROSPOVIDONE | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 9003398 | 2S7830E561 | 660mg | ||
| CROSPOVIDONE | ORAL | WAFER | 9003398 | 2S7830E561 | 97mg | ||
| CROSPOVIDONE | SUBCUTANEOUS | PELLET | 9003398 | 2S7830E561 | 2mg | ||
| CROSPOVIDONE | SUBLINGUAL | TABLET | 9003398 | 2S7830E561 | 60mg | ||
| CROSPOVIDONE | TOPICAL | EMULSION | 9003398 | 2S7830E561 | 1%w/w | ||
| CROSPOVIDONE | TOPICAL | LOTION | 9003398 | 2S7830E561 | 0.5%w/w | ||
| CROSPOVIDONE | TRANSDERMAL | FILM | 9003398 | 2S7830E561 | 4mg | ||
| CROSPOVIDONE | TRANSDERMAL | FILM, EXTENDED RELEASE | 9003398 | 2S7830E561 | 60mg | ||
| CROSPOVIDONE | TRANSDERMAL | SYSTEM | 9003398 | 2S7830E561 | 286mg | ||
| CROSPOVIDONE | VAGINAL | AEROSOL, FOAM | 9003398 | 2S7830E561 | 1%w/w | ||
| CROSPOVIDONE | VAGINAL | SUPPOSITORY | 9003398 | 2S7830E561 | 116.1mg | ||
| CUPRIC SULFATE | AURICULAR (OTIC) | SOLUTION | 7758998 | LRX7AJ16DT | NA | ||
| CUPRIC SULFATE | AURICULAR (OTIC) | SUSPENSION | 7758998 | LRX7AJ16DT | NA | ||
| CUTINA | SUBLINGUAL | TABLET | NA | 1.6mg | |||
| CYANOCOBALAMIN | ORAL | SOLUTION | 68199 | P6YC3EG204 | 60mg/1000ml | ||
| CYCLOMETHICONE | TOPICAL | AEROSOL, FOAM | 69430246 | NMQ347994Z | 5.26%w/w | ||
| CYCLOMETHICONE | TOPICAL | CREAM | 69430246 | NMQ347994Z | 13%w/w | ||
| CYCLOMETHICONE | TOPICAL | CREAM, AUGMENTED | 69430246 | NMQ347994Z | 7.6%w/w | ||
| CYCLOMETHICONE | TOPICAL | LOTION | 69430246 | NMQ347994Z | 1710mg | ||
| CYCLOMETHICONE | TOPICAL | SOLUTION | 69430246 | NMQ347994Z | 11.57%w/v | ||
| CYCLOMETHICONE 5 | TOPICAL | AEROSOL | 541026 | 0THT5PCI0R | 2.5%w/w | ||
| CYCLOMETHICONE 5 | TOPICAL | AEROSOL, FOAM | 541026 | 0THT5PCI0R | 144mg | ||
| CYCLOMETHICONE 5 | TOPICAL | CREAM, AUGMENTED | 541026 | 0THT5PCI0R | 260mg | ||
| CYCLOMETHICONE/DIMETHICONE COPOLYOL | TOPICAL | GEL | NA | 23mg | |||
| CYSTEINE | INTRAVENOUS | INJECTION, SOLUTION | 52904 | K848JZ4886 | 0.02%w/v | ||
| CYSTEINE | INTRAVENOUS | SOLUTION | 52904 | K848JZ4886 | 0.01%w/v | ||
| CYSTEINE HYDROCHLORIDE | INTRAVENOUS | INJECTION | 7048046 | ZT934N0X4W | 1.5%w/v | ||
| CYSTEINE HYDROCHLORIDE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 7048046 | ZT934N0X4W | 1mg | ||
| CYSTEINE HYDROCHLORIDE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 7048046 | ZT934N0X4W | 100mg | ||
| CYSTEINE HYDROCHLORIDE | INTRAVENOUS | INJECTION, SOLUTION | 7048046 | ZT934N0X4W | 100mg | ||
| CYSTEINE HYDROCHLORIDE | INTRAVENOUS | SOLUTION | 7048046 | ZT934N0X4W | 100mg | ||
| CYSTEINE HYDROCHLORIDE | ORAL | CAPSULE | 7048046 | ZT934N0X4W | NA | ||
| CYSTEINE HYDROCHLORIDE | ORAL | SUSPENSION | 7048046 | ZT934N0X4W | 3mg | ||
| CYSTEINE HYDROCHLORIDE | ORAL | TABLET, EXTENDED RELEASE | 7048046 | ZT934N0X4W | 24mg | ||
| CYSTEINE HYDROCHLORIDE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 7048046 | ZT934N0X4W | 32mg | ||
| CYSTEINE HYDROCHLORIDE ANHYDROUS | ORAL | TABLET, EXTENDED RELEASE | 52891 | A9U1687S1S | 50mg |
FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Office of Bioequivalence
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: September 19, 2024
Database Last Updated: October 19, 2024